United Microelectronics (UMC) At $2.58 Forms Top; Foundation Medicine (FMI) Sentiment Is 1.39

Foundation Medicine, Inc. provides various molecular information products in the United States. The company has market cap of $2.99 billion. The companyÂ’s molecular information platform includes proprietary methods and algorithms to analyze specimens across various types of cancer, as well as for incorporating that information into clinical care; and offers genomic information about each patientÂ’s individual cancer, enabling physicians to optimize treatments in clinical practice and biopharmaceutical companies to develop targeted oncology therapies. It currently has negative earnings. It provides clinical products, such as FoundationOne for solid tumors; FoundationOne Heme for blood cancers, or hematologic malignancies, including leukemia, lymphoma, and myeloma, as well as sarcomas and pediatric cancers; Foundation Assay for Circulating Tumor; FoundationFocus CDxBRCA, a diagnostic assay to aid in identifying women with ovarian cancer.

United Microelectronics Corporation (UMC) formed multiple top with $2.68 target or 4.00% above today’s $2.58 share price. United Microelectronics Corporation (UMC) has $6.27B valuation. The stock decreased 5.50% or $0.15 during the last trading session, reaching $2.58. About 163,829 shares traded. United Microelectronics Corporation (NYSE:UMC) has risen 14.77% since March 9, 2017 and is uptrending. It has underperformed by 1.93% the S&P500.

The stock increased 2.25% or $1.8 during the last trading session, reaching $81.8. About 127,142 shares traded. Foundation Medicine, Inc. (FMI) has risen 124.70% since March 9, 2017 and is uptrending. It has outperformed by 108.00% the S&P500.

Pier Capital Llc holds 0.98% of its portfolio in Foundation Medicine, Inc. for 140,562 shares. Gilder Gagnon Howe & Co Llc owns 1.52 million shares or 0.86% of their US portfolio. Moreover, Oppenheimer & Co Inc has 0.78% invested in the company for 723,480 shares. The New York-based Needham Investment Management Llc has invested 0.59% in the stock. Ipswich Investment Management Co. Inc., a Massachusetts-based fund reported 14,450 shares.

Among 4 analysts covering United Microelectronics Corp (NYSE:UMC), 2 have Buy rating, 1 Sell and 1 Hold. Therefore 50% are positive. United Microelectronics Corp had 6 analyst reports since August 11, 2015 according to SRatingsIntel. The company was downgraded on Thursday, July 27 by Credit Suisse. The company was downgraded on Thursday, July 27 by Bernstein. The company was upgraded on Wednesday, October 14 by JP Morgan. Credit Suisse upgraded the shares of UMC in report on Wednesday, January 24 to “Hold” rating. As per Tuesday, August 11, the company rating was downgraded by Zacks. The stock has “Buy” rating by HSBC on Wednesday, January 27.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: